Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhu, Zhaowei ^a   Zhang, Xiaohua ^a   Shen, Zhoujun ^a   Zhong, Shan ^a   Wang, Xianjin ^a   Lu, Yingli ^a   Xu, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; OBESITY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTEMATIC REVIEW;

COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; RISK; URINARY BLADDER NEOPLASMS;

EID: 84874275987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056662     Document Type: Article

References (71)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Pira E, Piolatto G, Negri E, Romano C, Boffetta P, et al. (2010) Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up. J Natl Cancer Inst 102: 1096-1099.
3. Bulbulyan MA, Figgs LW, Zahm SH, Savitskaya T, Goldfarb A, et al. (1995) Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol 24: 266-275.
4. Behrens T, Schill W, Ahrens W, (2009) Elevated cancer mortality in a German cohort of bitumen workers: extended follow-up through 2004. J Occup Environ Hyg 6: 555-561.
5. Ferrucci LM, Sinha R, Ward MH, Graubard BI, Hollenbeck AR, et al. (2010) Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study. Cancer 116: 4345-4353.
6. Guha N, Steenland NK, Merletti F, Altieri A, Cogliano V, et al. (2010) Bladder cancer risk in painters: a meta-analysis. Occup Environ Med 67: 568-573.
7. Fernandez MI, Lopez JF, Vivaldi B, Coz F, (2012) Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. J Urol 187: 856-861.
8. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC, (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306: 737-745.
9. Zimmet P, Alberti KG, Shaw J, (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
10. Ben Q, Xu M, Ning X, Liu J, Hong S, et al. (2011) Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 47: 1928-1937.
11. Wang C, Wang X, Gong G, Ben Q, Qiu W, et al. (2012) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130: 1639-1648.
12. Larsson SC, Wolk A, (2011) Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia 54: 1013-1018.
13. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, et al. (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer. Am J Gastroenterol 106: 1911-1921; quiz 1922.
14. Larsson SC, Orsini N, Brismar K, Wolk A, (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49: 2819-2823.
15. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA, (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128: 635-643.
16. Larsson SC, Andersson SO, Johansson JE, Wolk A, (2008) Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 44: 2655-2660.
17. Lee MY, Lin KD, Hsiao PJ, Shin SJ, (2012) The association of diabetes mellitus with liver, colon, lung, and prostate canceris independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism 61: 242-249.
18. Li C, Balluz LS, Ford ES, Okoro CA, Tsai J, et al. (2011) Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System. Diabetes Care 34: 1365-1368.
19. Marianne UY, Susan AO, Ulka BC, Carol EK, (2009) Incidence of cancer in a population-based cohort of patients with type 2 diabetes. Diabetes Metabolic Syndrome 3: 12-16.
20. Ogunleye AA, Ogston SA, Morris AD, Evans JM, (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101: 1199-1201.
21. Tseng CH, (2011) Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 54: 2009-2015.
22. Woolcott CG, Maskarinec G, Haiman CA, Henderson BE, Kolonel LN, (2011) Diabetes and urothelial cancer risk: the Multiethnic Cohort study. Cancer Epidemiol 35: 551-554.
23. Wotton CJ, Yeates DG, Goldacre MJ, (2011) Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies. Diabetologia 54: 527-534.
24. Hemminki K, Li X, Sundquist J, Sundquist K, (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15: 548-555.
25. Chung H, (2009) Diabetes and risk of death from cancer of the prostate, kidney, and urinary bladder. Urology 74: S36-S37.
26. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, et al. (2012) Mortality After Incident Cancer in People With and Without Type 2 Diabetes:Impact of metformin on survival. Diabetes Care 35: 299-304.
27. Lam EK, Batty GD, Huxley RR, Martiniuk AL, Barzi F, et al. (2011) Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 22: 730-738.
28. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K, (2012) The impact of type 2 diabetes mellitus on cancer-specific survival: A follow-up study in sweden. Cancer 118: 1353-1361.
29. Seshasai SR, Kaptoge S, Thompson A, Di AE, Gao P, et al. (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364: 829-841.
30. Tseng CH, Chong CK, Tseng CP, Chan TT, (2009) Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Ann Med 41: 371-379.
31. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting.Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
32. Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, et al. (2011) Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 26: 863-876.
33. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
34. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
35. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
36. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
37. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, et al. (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-basedcohort study in Sweden. J Natl Cancer Inst 95: 1797-1800.
38. Shu X, Ji J, Li X, Sundquist J, Sundquist K, et al. (2010) Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 27: 791-797.
39. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K, (2012) Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev 21: 300-306.
40. Tripathi A, Folsom AR, Anderson KE, (2002) Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95: 2316-2323.
41. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
42. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, et al. (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7: 253-259.
43. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202.
44. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ, (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167.
45. Ragozzino M, Melton LJ 3rd, Chu CP, Palumbo PJ, (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35: 13-19.
46. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314.
47. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365.
48. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, et al. (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92: 2070-2075.
49. Kessler II, (1970) Cancer mortality among diabetics. J Natl Cancer Inst 44: 673-686.
50. Verlato G, Zoppini G, Bonora E, Muggeo M, (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona(Italy). Diabetes Care 26: 1047-1051.
51. Zhang F, Yang Y, Skrip L, Hu D, Wang Y, et al. (2012) Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. Acta Diabetol 49Suppl 1: 235-246.
52. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, et al. (2011) Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 34: 528-540.
53. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, et al. (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32: 1620-1625.
54. Colhoun HM, (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52: 1755-1765.
55. Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, et al. (2011) Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care 34: 2323-2328.
56. Noto H, Goto A, Tsujimoto T, Noda M, (2012) Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLOS ONE 7: e33411.
57. Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, et al. (2012) Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist 17: 813-822.
58. Colmers IN, Bowker SL, Johnson JA, (2012) Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab 38: 475-484.
59. Colmers IN, Bowker SL, Majumdar SR, Johnson JA, (2012) Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. CMAJ 184: E675-683.
60. Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, et al. (2011) Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 34: 916-922.
61. Piccinni C, Motola D, Marchesini G, Poluzzi E, (2011) Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Diabetes Care 34: 1369-1371.
62. Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, et al. (2012) Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia 55: 1953-1962.
63. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R, (2009) Diabetes and cancer. Endocr Relat Cancer 16: 1103-1123.
64. Vigneri R, (2009) Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol 5: 651-652.
65. Jones JI, Clemmons DR, (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
66. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, et al. (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol 169: 714-717.
67. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, et al. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57: 4667-4672.
68. Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, et al. (2003) Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. Urology 61: 359-364.
69. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101.
70. Hwang EC, Kim YJ, Hwang IS, Hwang JE, Jung SI, et al. (2011) Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study. Int J Urol 18: 769-776.
71. Kessler TM, Ochsner K, Studer UE, Thalmann GN, (2008) Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution. Eur Urol 53: 1040-1046.